⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphonic Acid SCHEMBL10946315 | 0.88 | ALDH1A1 (0.30) | — | |
| SCHEMBL6053306 | 0.83 | PTPN1 (0.38) | — | |
| SCHEMBL27808604 | 0.79 | FDPS (0.40) | — | |
| SCHEMBL6225784 | 0.79 | FDPS (0.40) | — | |
| SCHEMBL1396820 | 0.77 | ENPEP (0.46) | — | |
| SCHEMBL3806259 | 0.75 | — | — | |
| SCHEMBL302911 | 0.74 | — | — | |
| SCHEMBL3503928 | 0.74 | — | — | |
| SCHEMBL4536812 | 0.74 | — | — | |
| SCHEMBL8933408 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1994013688-A1 | DNA-ARMED RIBOZYMES AND MINIZYMES | GENE SHEARS PTY. LIMITED (AU) | 1994-06-23 | — | — | WO | claimed |
| US-9868955-B2 | Human toll-like receptor inhibitors and methods of use thereof | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2018-01-16 | — | — | US | disclosed |
| EP-2900823-B1 | HUMAN TOLL-LIKE RECEPTOR INHIBITORS AND METHODS OF USE THEREOF | DYNAVAX TECH CORP (US) | 2017-11-08 | — | — | EP | disclosed |
| EP-2209896-B1 | METHODS AND COMPOSITIONS FOR INHIBITION OF IMMUNE RESPONSES AND AUTOIMMUNITY | DYNAVAX TECH CORP (US) | 2017-03-01 | — | — | EP | disclosed |
| EP-2361980-B1 | Methods and compositions for inhibition of immune responses and autoimmunity | DYNAVAX TECH CORP (US) | 2016-12-07 | — | — | EP | disclosed |
| US-9476053-B2 | Methods and compositions for inhibition of immune responses and autoimmunity | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2016-10-25 | — | — | US | disclosed |
| US-9347064-B2 | Methods of treatment using TLR7 and/or TLR9 inhibitors | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2016-05-24 | — | — | US | disclosed |
| EP-2582398-B1 | METHODS OF TREATMENT USING TLR7 AND/OR TLR9 INHIBITORS | DYNAVAX TECH CORP (US) | 2016-04-13 | — | — | EP | disclosed |
| CN-101052643-B | Methods and compositions for inhibiting innate immune response and autoimmunity | DYNAVAX TECHNOLOGIES CORP. (US) | 2016-01-06 | — | — | CN | disclosed |
| US-9228184-B2 | Human toll-like receptor inhibitors and methods of use thereof | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2016-01-05 | — | — | US | disclosed |
| US-6117657-A | ENZYMATIC NUCLEIC ACID MOLECULE CONTAINING ONE OR MORE NON-NUCLEOTIDE MIMETICS, AND HAVING ACTIVITY TO CLEAVE AN RNA OR DNA MOLECULE | RIBOZYME PHARMACEUTICALS, INC. (US) | 2000-09-12 | — | — | US | disclosed |
| US-5891683-A | Non-nucleotide containing enzymatic nucleic acid | RIBOZYME PHARMACEUTICALS, INC. (US) | 1999-04-06 | — | — | US | disclosed |
| CN-1197463-A | Dispersions of polyurethanes containing carbonyl groups in the ketone function | BASF AG (DE) | 1998-10-28 | — | — | CN | disclosed |
| EP-0787044-A4 | POLYMERIZED PHOSPHOLIPID MEMBRANE MEDIATED SYNTHESIS OF METAL NANOPARTICLES | US NAVY (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0799313-A2 | METHOD AND REAGENT FOR TREATMENT OF ARTHRITIC CONDITIONS, INDUCTION OF GRAFT TOLERANCE AND REVERSAL OF IMMUNE RESPONSES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1997-10-08 | — | — | EP | disclosed |
| EP-0787044-A1 | POLYMERIZED PHOSPHOLIPID MEMBRANE MEDIATED SYNTHESIS OF METAL NANOPARTICLES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE NAVY (US) | 1997-08-06 | — | — | EP | disclosed |
| US-5560960-A | Polymerized phospholipid membrane mediated synthesis of metal nanoparticles | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1996-10-01 | — | — | US | disclosed |
| WO-1996018736-A2 | METHOD AND REAGENT FOR TREATMENT OF ARTHRITIC CONDITIONS, INDUCTION OF GRAFT TOLERANCE AND REVERSAL OF IMMUNE RESPONSES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1996-06-20 | — | — | WO | disclosed |
| WO-1996014165-A1 | POLYMERIZED PHOSPHOLIPID MEMBRANE MEDIATED SYNTHESIS OF METAL NANOPARTICLES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1996-05-17 | — | — | WO | disclosed |
| WO-1994013688-A1 | DNA-ARMED RIBOZYMES AND MINIZYMES | GENE SHEARS PTY. LIMITED (AU) | 1994-06-23 | — | — | WO | disclosed |